A reminder to everyone to chill... and look at things from a broader perspective. Be less pessimistic and a little bit more optimistic.
Why I remain optimistic on Regis Corporation's ($RGS) successful turnaround through cost-cutting, and growth initiatives under new management.
I covered Haw Par Group back in 2019. Hence I think it is time to revisit this company which is trading at multi year lows.
A valuable read for investors looking to improve their decision-making skills in the stock market.
Discover the potential of investing in Medpace Holdings Inc ($MEDP), a leading global CROin the healthcare industry.
My annual investment review for 2022. This year has been a rollercoaster for the stock market, here are the key takeaways from my portfolio.
Navigating the stock market: comparing the pros and cons of dollar cost averaging and lump sum investing. Which is right strategy for you?
Books can be a useful resource for investors. Here are the 3 books that got me started in value investing.
We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.
VolitionRx is commercially introducing a product with a huge addressable market. If successful, the market will rerate the stock.